Learn more

JAPAN IMMUNO INC

Overview
  • Total Patents
    57
About

JAPAN IMMUNO INC has a total of 57 patent applications. Its first patent ever was published in 1989. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are SANGAMO THERAPEUTICS INC, ROSSOMANDO ANTHONY and ALG COMPANY.

Patent filings per year

Chart showing JAPAN IMMUNO INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Nakamura Tetsuo 36
#2 Okamoto Hiroaki 20
#3 Mishiro Shunji 12
#4 Ando Kunio 8
#5 Okabe Masato 6
#6 Kishimoto Jun-Ichi 3
#7 Kishimoto Junichi 3
#8 Nishikawa Yoshiyuki 2
#9 Goto Sachiko 2
#10 Hosokawa Tomoyoshi 2

Latest patents

Publication Filing date Title
CA2514941A1 High-expression vector for animal cells
US5766867A Non-A, non-B hepatitis related nucleic acids, proteins, peptides, antigens, and antibodies
WO9404520A1 Ascofuranone, and hypolipidemic agent, hypoglycemic agent and glycation inhibitor each containing ascofuranone derivative as active ingredient
EP0559425A1 Use of proteins belonging to the transferrin/lactoferrin family for potentiating the immune system
US5427909A Oligonucleotides and determination system of HCV genotypes
US5428145A Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
EP0532167A2 Non-A, Non-B Hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
EP0510952A1 Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus
CA2065690A1 Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
EP0500236A1 Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents
EP0488812A1 Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents
EP0485209A1 Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
US5198419A Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
CA2044535A1 Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
EP0461863A1 Oligonucleotide primers, and their application for high-fidelity detection of non-A, non-B hepatitis virus
US5176994A Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein
EP0441644A2 Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents